Breast Cancer [0.03%]
乳腺癌
Norbert Avril
Norbert Avril
Histopathologic and Metabolic Criteria for Assessment of Treatment Response in Breast Cancer [0.03%]
乳腺癌治疗反应的病理和代谢评估标准
Stefanie Sassen,Falko Fend,Norbert Avril
Stefanie Sassen
Increasing use of neoadjuvant chemotherapy in locally advanced breast cancer necessitates methods for evaluation of therapeutic response. Histopathology provides accurate assessment of treatment efficacy but only approximately 20% of breast...
Changes in Glucose Metabolism and Blood Flow Following Chemotherapy for Breast Cancer [0.03%]
乳腺癌化疗后的糖代谢和血流的变化
David A Mankoff,Lisa K Dunnwald
David A Mankoff
This article focuses on this application of positron emission tomography (PET) to breast cancer. The article first reviews the PET methodology used for breast cancer response assessment, with an emphasis on quantitative methods. This is fol...
Jean-Mathieu Beauregard,Éric Turcotte,François Bénard
Jean-Mathieu Beauregard
A high proportion of breast cancers express estrogen and progesterone receptors. This can guide oncologists on hormonal therapy's suitability for breast cancer. With second-line hormonal therapy agents such as aromatase inhibitors and pure ...
FDG-PET and PET/CT in Radiation Therapy Simulation and Management of Patients Who Have Primary and Recurrent Breast Cancer [0.03%]
用于乳腺癌初始和复发病例的放射治疗模拟和管理方面的FDG-正电子发射断层成像及PET/CT扫描技术
Dwight E Heron,Sushil Beriwal,Norbert Avril
Dwight E Heron
Radiation therapy is an important component in breast cancer management. Localization and delineation of gross tumor volumes is determined by anatomical imaging using CT and MRI. Recent developments allow the delivering of radiation doses m...
Christopher J Thompson
Christopher J Thompson
Positron emission tomography (PET) is becoming widely accepted for the diagnosis and staging of cancer. Whole-body PET can detect not only primary breast cancer but distant metastases as well. Recently, several groups have developed small P...
Detection of Bone Metastases in Breast Cancer by Positron Emission Tomography [0.03%]
正电子发射断层扫描检测乳腺癌骨转移病灶
Holger Schirrmeister
Holger Schirrmeister
Positron emission tomography (PET) is able to demonstrate changes in the metabolism of malignant tumors and metastases before they become visible on anatomical imaging. The skeleton is the most common site of distant metastases of breast ca...
Diagnosis of Recurrent and Metastatic Disease Using F-18 Fluorodeoxyglucose-Positron Emission Tomography [0.03%]
使用氟脱氧葡萄糖正电子发射断层扫描诊断复发和转移性疾病
William B Eubank
William B Eubank
One of the major strengths of F-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) in breast cancer imaging is in the evaluation of patients who have suspected loco-regional recurrence or distant metastasis. In general, FDG-PET is...
F-18 Fluorodeoxyglucose-Positron Emission Tomography Imaging for Primary Breast Cancer and Loco-Regional Staging [0.03%]
原发性乳腺癌及局部区域分期的~(18)F-FDG正电子发射断层扫描显像
Norbert Avril,Lee P Adler
Norbert Avril
Breast cancer is the most common female malignancy in Western countries. The limitations of mammography, ultrasound and MRI do not allow reliable identification of primary breast cancer at early stages. Functional breast imaging with positr...
Robert H Mach
Robert H Mach